Northwest Biotherapeutics reported $32.94M in Debt for its fiscal quarter ending in September of 2023.





Debt Change Date
Agenus USD 35.54M 2.34M Mar/2025
AstraZeneca USD 32.24B 1.68B Jun/2026
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Celldex Therapeutics USD 1.91M 428K Mar/2026
Eisai JPY 186.08B 50.58B Mar/2026
Merck USD 49.12B 222M Mar/2026
Northwest Biotherapeutics USD 32.94M 6.93M Sep/2023
Pfizer USD 63.19B 536M Jun/2026
Plus Therapeutics USD 3.98M 372K Dec/2023
Roche Holding CHF 33.03B 1.41B Jun/2025